The radiosensitivity index predicts benefit from HDR brachytherapy in high-risk prostate cancer

Thiruthaneeswaran, N., Bibby, B.A.S., Pereira, R. et al. (8 more authors) (2020) The radiosensitivity index predicts benefit from HDR brachytherapy in high-risk prostate cancer. In: Radiotherapy & Oncology. ESTRO 2020, 28 Nov - 01 Dec 2020, Online. Elsevier , S1086-S1087.

Metadata

Item Type: Proceedings Paper
Authors/Creators:
Dates:
  • Published: November 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Oncology
Depositing User: Symplectic Publications
Date Deposited: 13 Nov 2024 15:13
Last Modified: 13 Nov 2024 15:13
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/S0167-8140(21)01970-8
Related URLs:
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)